Roger R. Hopkins
Analyst · Stifel, Nicolaus
Thanks, Justin. Good morning, everyone. My comments this morning are consistent with our disclosures in Form 10-Q, our earnings press release and our supplemental data report filed this morning with the SEC. Normalized funds from operations for the second quarter of 2012 rose 6% over the same period in 2011, primarily as a result of revenues from our new investments funded at $82.4 million in 2011 and $29.6 million so far in 2012. Lease revenues from our tenant Legend Healthcare increased $1.2 million due to new investments made in the fourth quarter of 2011 and the second quarter of 2012. Normalized FFO for the second quarter of 2012 was $21,386,000 or $0.77 per diluted share compared with normalized FFO of $20,179,000 or $0.73 per diluted share in the second quarter of 2011. Normalized funds available for distribution for the second quarter of 2012 was $21,010,000 or $0.76 per diluted share compared with $19,724,000 or $0.71 per diluted share for the same period in 2011. Normalized FFO and normalized FAD for the second quarter of 2012 excluded the impact on net income of write-offs and expenses related to an early lease termination, which I will discuss in a moment, and other adjustments of $155,000. Normalized FFO and normalized FAD for the same period in 2011 excluded the impact on net income of gains of $8,655,000 on the sale of marketable securities and a $988,000 change in the fair value of a previous interest rate swap agreement. Net income for the second quarter of 2012 was $16,928,000 or $0.61 per diluted share compared with net income of $25,117,000 or $0.90 per diluted share for the same period in 2011. Net income for the second quarter of 2012 and 2011 includes the accounting impact of the adjustments, write-offs and other expenses mentioned above. Large transactions that are infrequent or unpredictable in nature that affect net income are adjusted in our reconciliation of our net income to normalized FFO and normalized FAD. It is included in our earnings release at Form 10-Q and the supplemental data report. In June 2012, due to material noncompliance with our lease terms, we terminated our lease with a former tenant of 4 assisted living and memory care facilities in Minnesota and transitioned the least to a new tenant, White Pine Senior Living. As a result, during the second quarter, we realized lower cash payments of $450,000 from our former tenant. We wrote off an additional $126,000 in billed receivables. We incurred $171,000 in legal and other direct expenses and incurred a noncash write-off of straight line rent receivables for accounting purposes of $963,000. The former lease provided for an annual lease amount of $2,204,000, whereas the new lease provides for a higher annual lease amount of $2,338,000 plus annual fixed escalators. In addition, the first 6 months of the lease contains additional supplemental rent payments of $410,000 that will be recognized in the income over the initial term of the lease of 13 years. Our revenues for the second quarter of 2012 were up 10% compared to the same period in 2011 when you exclude the impact of the early lease termination in 2012 and the gains on sales of marketable securities in 2011. Straight line rental income was only $14,000 in the second quarter after the write-off of $963,000 related to the Minnesota lease. Rental income for each year excludes the revenues from those properties that were sold or that made the accounting criteria as being held for sale. There remains 5 skilled nursing facilities in Texas that we plan to sell to our current tenant when they obtain long-term HUD financing. These properties are classified as assets held for sale on our balance sheet and as discontinued operations in our income statement. We plan to defer recognition of the tax gain on the sale of these properties when they're sold. Income from properties classified as discontinued operations was $1,247,000 in the second quarter of 2012 compared to $1,275,000 during the same period in 2011. Rental income from our owned assets represented 87% of our second quarter revenue. Depreciation expense increased $466,000 during the second quarter of 2012 compared to the same period in 2011 as a result of our new real estate investments in 2011 and 2012 in facilities that are leased to Legend Healthcare. Our interest expense and amortization of loan costs was $747,000 for the second quarter of 2012 compared to $601,000 for the same period in 2011 when we exclude the change of $988,000 in the fair value of the previous interest rate swap agreement in 2011. The higher interest expense is indicative of our higher borrowings to fund our new investments in healthcare real estate. Our general and administrative costs for the second quarter of 2012 increased $300,000 from the same period in 2011 due primarily to a $171,000 in direct expenses related to the early lease termination described above to $95,000 of transaction costs of an acquisition classified as a business combination for accounting purposes, a $90,000 legal settlement related to one of our subsidiaries and was partially offset by lower stock-based compensation expense and corporate overhead. Stock-based compensation expense was $248,000 for the second quarter of 2012 and is expected to be the same for each of the next 2 quarters. Altogether, our second quarter normalized operating results met our internal forecast. Normalized funds from operations for the 6-month period ended June 30, 2012, rose 11.8% over the same period in 2011, primarily as a result of revenues from our new investments funded in 2011 and 2012. Lease revenues from our tenant Legend Healthcare increased $2.4 million due to new investments made in the fourth quarter of 2011 and the second quarter of 2012. Normalized FFO for 2012 was $42,761,000 or $1.54 per diluted share compared with normalized FFO of $38,256,000 or $1.38 per diluted share in 2011. Normalized funds available for distribution in 2012 was $43,093,000 or $1.55 per diluted share compared with $39,458,000 or $1.42 per diluted share for the same period in 2011. Normalized FFO and normalized FAD for 2012 excluded the impact on net income of previous write-offs -- on net income of write-offs and the expenses related to the early lease termination discussed previously and other adjustments. Normalized FFO and normalized FAD for the same period in 2011 excluded the impact on net income of gains of $8,809,000 on the sale of marketable securities and a $266,000 change in the fair value of a previous interest rate swap agreement. Our debt at June 30 consisted of our bank term loan borrowings of $120 million. We have a low debt to book capitalization of only 21.2% and a low debt to market capitalization of only 8.2%. We expect our normal monthly cash flows, borrowings on our revolving credit facility and potential longer-term debt will be the primary sources of capital to fund our new real estate investments for the remainder of 2012. Though we plan to leverage our balance sheet to fund our new real estate investments in the short term, we intend that our debt to total book and market capitalization remain at a level that is below our larger peers in the REIT industry. We ended the second quarter of 2012 with cash and marketable securities of $22,942,000. This morning, we announced that our third quarter dividend will increase from $0.65 to $0.67 per share for shareholders of record on September 28, 2012, and will be paid on November 9, 2012. I'd now like to turn the call back over to Justin with comments about our 2012 normalized FFO guidance.